Aehr Test Systems (AEHR) - Stock Analysis
Last updated: Jun 13, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Multiple AI/data-center order wins create strong near-term evidence, including an April 16 record $41M follow-on order from a lead hyperscale customer. Fiscal Q3 bookings were $37.2M with book-to-bill above 3.5x, and the stock gained about 129% over 21 trading days.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong Liquidity ⢠Ongoing Cash Burn ⢠Weak Profitability AEHR has a very strong, low-debt balance sheet, but persistent losses, negative cash flow, and a rich valuation make it a speculative investment despite solid liquidity.
Price Behavior
Key Price Behavior Insights: ⢠Support Holding ⢠Sharp Reversal ⢠Range Resistance Support Level: $93-$95 Resistance Level: $113-$117 AEHR remained slightly up over the last month, with buyers defending the low-$90s and momentum still constructive, but the sharp drop from $116.58 to $93.32 keeps near-term volatility high unless it reclaims $113-$117.
Sentiment & News
Key News Insights: ⢠Price Momentum ⢠AI Tailwinds ⢠Investor Outreach AEHR showed strong price momentum and rising investor visibility, boosted by favorable AI infrastructure sentiment and conference outreach.
AI Summary
AEHR's investment case has materially improved because record bookings/backlog and >3.5x book-to-bill point to a real AI/package-level burn-in growth inflection, but the stock already prices in that shift while profitability, cash flow, and backlog-to-revenue conversion remain unproven, making execution and customer concentration the key risks to watch.
Description
Aehr Test Systems designs and supplies test and burn-in equipment for logic, memory and optical integrated circuits, supporting both wafer-level and packaged-device verification. Its product set includes systems and handling solutions that enable full-wafer contact testing, singulated die and module burn-in, and compact single-wafer reliability checks across a range of device types and power levels. The company was incorporated in 1977 and is based in Fremont, California.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Apr 30 | May 7 | AEHR | Aehr Test Systems | Multiple AI/data-center order wins create strong near-term evidence, including an April 16 record $41M follow-on order from a lead hyperscale customer. Fiscal Q3 bookings were $37.2M with book-to-bill above 3.5x, and the stock gained about 129% over 21 trading days. | Closed | +0.8% |
| Apr 20 | Apr 27 | AEHR | Aehr Test Systems | One of the clearest fresh catalyst setups: record $41 million follow-on order announced on 2026-04-16 and $37.2 million bookings with book-to-bill above 3.5x on 2026-04-07. Shares surged about 160% over 21 trading days, showing exceptional momentum tied to AI-related burn-in demand. | Closed | -1.8% |
| Apr 13 | Apr 20 | AEHR | Aehr Test Systems | AEHR shows classic speculative heat: ~102% 21âday price surge, strong order bookings (bookâtoâbill >3.5x, AI/datacenter and silicon photonics wins) and raised 2H FY26 bookings visibility, making it a highâvolatility, orderâdriven momentum trade over the coming sessions. | Closed | +25.8% |
| Apr 2 | Apr 9 | AEHR | Aehr Test Systems | High-risk semiconductor test beneficiary with an imminent catalyst: multiple recent production orders (FOX wafer-level systems, silicon-photonics and GaN programs), reinstated H2 revenue guidance ($25â30M) and a sharp rebound (~+31% from March 30 to April 1) into the 2026-04-07 Q3 earnings release create a classic near-term event/momentum setup. | Closed | +55.4% |
| Mar 9 | Mar 16 | AEHR | Aehr Test Systems | Semicap name with stacked recent orders: in Febâearly Mar 2026 announced multiple production-stage and wafer-level burn-in orders (including a $14M FOX + WaferPak order on 2026-02-26 and a follow-on silicon-photonics order on 2026-03-03). Stock ran ~55% into a 44.03 high then pulled back ~19% to 35.61 by 2026-03-06, leaving a high-volatility setup where confirmation of order-to-revenue conversion could trigger another sharp upside leg. | Closed | -8.3% |
| Feb 23 | Mar 2 | AEHR | Aehr Test Systems | An initial production purchase order from a leading hyperscaler for multiple Sonoma systems and more than $5.5m in recent Q3 orders, tied to nextâgen AI processors, is catalyzing strong technical momentum (break around $34) and elevated investor interest, positioning AEHR for nearâterm upside as those orders convert to reported revenue despite weak recent cash flow and margins. | Closed | +28.3% |
| Dec 17 | Dec 24 | AEHR | Aehr Test Systems | Record Q3 revenues with strong AI/data center product demand, production capacity expansion, institutional buying, and improving gross margins underpin short-term growth, although unprofitability and technical price volatility suggest cautious optimism. | Closed | +2.7% |